Nutriband (NTRBW) Projected to Post Quarterly Earnings on Friday

Nutriband (NASDAQ:NTRBW) is expected to announce its resultson Friday, May 1st. Analysts expect the company to announce earnings of ($1.89) per share and revenue of $0.7650 million for the quarter.

Nutriband Stock Performance

Shares of NTRBW opened at $1.30 on Friday. Nutriband has a 12 month low of $0.80 and a 12 month high of $4.50. The firm has a fifty day simple moving average of $1.29 and a 200 day simple moving average of $1.57.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.